Physiological rationale for co-treatment with diuretics in heart failure.
作者信息
Cohn J N
机构信息
Department of Medicine, University of Minnesota Medical School, Minneapolis 55455.
出版信息
Br Heart J. 1994 Aug;72(2 Suppl):S63-7. doi: 10.1136/hrt.72.2_suppl.s63.
Abstract
摘要
相似文献
1
Physiological rationale for co-treatment with diuretics in heart failure.心力衰竭中联合使用利尿剂的生理学原理。
Br Heart J. 1994 Aug;72(2 Suppl):S63-7. doi: 10.1136/hrt.72.2_suppl.s63.
2
[Diastolic cardiac insufficiency].舒张性心功能不全
Clin Ter. 2002 Sep-Oct;153(5):355-7.
3
Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.利尿剂增加剂量对 51 例因左心室射血分数降低而接受β受体阻滞剂、血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂治疗的有症状心力衰竭患者的症状、体重、6 分钟步行距离和左心室收缩及舒张功能的超声心动图测量值的影响。
Am J Ther. 2009 Jan-Feb;16(1):5-7. doi: 10.1097/MJT.0b013e31813e6452.
4
A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction.
Eur J Heart Fail. 2004 Dec;6(7):927-35. doi: 10.1016/j.ejheart.2004.02.002.
5
Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.评估充血性心力衰竭的治疗：利尿剂、血管扩张剂和血管紧张素转换酶抑制剂。
Pharmacotherapy. 1993 Sep-Oct;13(5 Pt 2):82S-87S.
6
[Vasodilators in heart failure. Basis for their use].[心力衰竭中的血管扩张剂。其应用的基础]
Arq Bras Cardiol. 1994 Dec;63(6):531-6.
7
Congestive heart failure: what should be the initial therapy and why?充血性心力衰竭：初始治疗应该是什么以及为什么？
Am J Cardiovasc Drugs. 2002;2(1):1-6. doi: 10.2165/00129784-200202010-00001.
8
The management of chronic heart failure.
N Engl J Med. 1996 Aug 15;335(7):490-8. doi: 10.1056/NEJM199608153350707.
9
Current and novel pharmacologic approaches in advanced heart failure.
Am Heart J. 1998 Jun;135(6 Pt 2 Su):S249-63. doi: 10.1016/s0002-8703(98)70254-6.
10
[Present status of drug therapy in chronic heart dysfunction].
Nihon Naika Gakkai Zasshi. 1995 Mar 10;84(3):354-9.
引用本文的文献
1
Effect of Shenmai Injection on ventricular diastolic function in patients with chronic heart failure: An assessment by tissue Doppler imaging.参麦注射液对慢性心力衰竭患者心室舒张功能的影响：组织多普勒成像评估。
Chin J Integr Med. 2010 Apr;16(2):173-5. doi: 10.1007/s11655-010-0173-1. Epub 2010 May 16.
2
Clinical case studies in heart failure management.心力衰竭管理中的临床病例研究
Br J Clin Pharmacol. 1999 Mar;47(3):239-47. doi: 10.1046/j.1365-2125.1999.00882.x.
本文引用的文献
1
Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure.异山梨醇二硝酸酯对充血性心力衰竭运动能力的即时和长期影响对比
Am J Med. 1980 Oct;69(4):559-66. doi: 10.1016/0002-9343(80)90468-4.
2
Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.通过血浆激素水平评估交感神经系统和肾素-血管紧张素系统的活性及其与充血性心力衰竭血流动力学异常的关系。
Am J Cardiol. 1982 May;49(7):1659-66. doi: 10.1016/0002-9149(82)90243-0.
3
Increased plasma arginine vasopressin levels in patients with congestive heart failure.充血性心力衰竭患者血浆精氨酸加压素水平升高。
J Am Coll Cardiol. 1983 Jun;1(6):1385-90. doi: 10.1016/s0735-1097(83)80040-0.
4
Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.在慢性硝酸异山梨酯治疗充血性心力衰竭期间运动能力的改善以及动脉和静脉耐受性的差异
Circulation. 1983 Apr;67(4):817-22. doi: 10.1161/01.cir.67.4.817.
5
Treadmill exercise in assessment of the functional capacity of patients with cardiac disease.跑步机运动在评估心脏病患者功能能力中的应用
Am J Cardiol. 1972 Nov;30(7):757-62. doi: 10.1016/0002-9149(72)90151-8.
6
Treatment of refractory heart failure with infusion of nitroprusside.硝普钠输注治疗难治性心力衰竭。
N Engl J Med. 1974 Sep 19;291(12):587-92. doi: 10.1056/NEJM197409192911201.
7
Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure.
Ann Intern Med. 1974 Dec;81(6):777-80. doi: 10.7326/0003-4819-81-6-777.
8
Vascular hemodynamic impedance in congestive heart failure.充血性心力衰竭中的血管血流动力学阻抗。
Am J Cardiol. 1985 Feb 1;55(4):423-7. doi: 10.1016/0002-9149(85)90387-x.
9
Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration.
Am Heart J. 1987 Jul;114(1 Pt 1):148-52. doi: 10.1016/0002-8703(87)90318-8.
10
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.血管扩张剂疗法对慢性充血性心力衰竭死亡率的影响。退伍军人管理局合作研究的结果。
N Engl J Med. 1986 Jun 12;314(24):1547-52. doi: 10.1056/NEJM198606123142404.
Zotero 插件